Your browser doesn't support javascript.
loading
Polyhydroxyalkanoates and their advances for biomedical applications.
Gregory, David A; Taylor, Caroline S; Fricker, Annabelle T R; Asare, Emmanuel; Tetali, Santosh S V; Haycock, John W; Roy, Ipsita.
Afiliación
  • Gregory DA; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
  • Taylor CS; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
  • Fricker ATR; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
  • Asare E; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
  • Tetali SSV; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
  • Haycock JW; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK.
  • Roy I; Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield, UK; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK. Electronic address: i.roy@sheffield.ac.uk.
Trends Mol Med ; 28(4): 331-342, 2022 04.
Article en En | MEDLINE | ID: mdl-35232669
ABSTRACT
Polyhydroxyalkanoates (PHAs) are sustainable, versatile, biocompatible, and bioresorbable polymers that are suitable for biomedical applications. Produced via bacterial fermentation under nutrient-limiting conditions, they are uncovering a new horizon for devices in biomedical applications. A wide range of cell types including bone, cartilage, nerve, cardiac, and pancreatic cells, readily attach grow and are functional on PHAs. The tuneable physical properties and resorption rates of PHAs provide a toolbox for biomedical engineers in developing devices for hard and soft tissue engineering applications and drug delivery. The versatility of PHAs and the vast range of different PHA-based prototypes are discussed. Current in vitro, ex vivo, and in vivo development work are described and their regulatory approvals are reviewed.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polihidroxialcanoatos Idioma: En Revista: Trends Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polihidroxialcanoatos Idioma: En Revista: Trends Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article